Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 741 to 750 of 881

TitleReference numberPublishedLast updated
Secukinumab for treating moderate to severe plaque psoriasisTA350
Secukinumab for treating moderate to severe plaque psoriasis in children and young peopleTA734
Selective internal radiation therapies for treating hepatocellular carcinomaTA688
Selinexor with bortezomib and dexamethasone for previously treated multiple myelomaTA974
Selinexor with dexamethasone for treating relapsed and refractory multiple myeloma after 4 or more treatmentsTA970
Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and overTA1038
Selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and overTA1039
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancerTA1042
Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancerTA911
Semaglutide for managing overweight and obesityTA875

Results per page

  1. 10
  2. 25
  3. 50
  4. All